MX9203493A - Surfactantes y remedios para sindrome de tension respiratoria que contienen los mismos. - Google Patents

Surfactantes y remedios para sindrome de tension respiratoria que contienen los mismos.

Info

Publication number
MX9203493A
MX9203493A MX9203493A MX9203493A MX9203493A MX 9203493 A MX9203493 A MX 9203493A MX 9203493 A MX9203493 A MX 9203493A MX 9203493 A MX9203493 A MX 9203493A MX 9203493 A MX9203493 A MX 9203493A
Authority
MX
Mexico
Prior art keywords
surfactant
remedies
surfactants
surface tension
tension syndrome
Prior art date
Application number
MX9203493A
Other languages
English (en)
Spanish (es)
Inventor
Tsunemoto Takei
Yohsaku Kanazawa
Kazuo Masuda
Yuji Tanaka
Original Assignee
Tokyo Tanabe Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12518415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9203493(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tokyo Tanabe Co filed Critical Tokyo Tanabe Co
Publication of MX9203493A publication Critical patent/MX9203493A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
MX9203493A 1983-03-10 1992-06-26 Surfactantes y remedios para sindrome de tension respiratoria que contienen los mismos. MX9203493A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58038189A JPS59164724A (ja) 1983-03-10 1983-03-10 サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤

Publications (1)

Publication Number Publication Date
MX9203493A true MX9203493A (es) 1992-08-01

Family

ID=12518415

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203493A MX9203493A (es) 1983-03-10 1992-06-26 Surfactantes y remedios para sindrome de tension respiratoria que contienen los mismos.

Country Status (10)

Country Link
US (1) US4603124A (OSRAM)
EP (1) EP0119056B1 (OSRAM)
JP (1) JPS59164724A (OSRAM)
AT (1) ATE55908T1 (OSRAM)
AU (1) AU562676B2 (OSRAM)
CA (1) CA1208129A (OSRAM)
DE (1) DE3483055D1 (OSRAM)
GR (1) GR81930B (OSRAM)
IE (1) IE57006B1 (OSRAM)
MX (1) MX9203493A (OSRAM)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430020A (en) * 1984-12-11 1995-07-04 Scios Nova Inc. Recombinant alveolar surfactant protein
US5110806A (en) * 1985-06-26 1992-05-05 The Regents Of The University Of California Lung surfactant compositions
DE3528934A1 (de) * 1985-08-13 1987-02-26 Feldmuehle Ag Gleitelement aus keramischem werkstoff
EP0240550A4 (en) * 1985-09-26 1989-09-19 Genetics Inst TENSIO-ACTIVE PULMONARY PROTEINS.
US5256569A (en) * 1986-01-21 1993-10-26 Chisso Corporation Transesterification process for otereoselection of enantiomers of secondary alcohols using pseudomonas lipase with no added solvent
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5207220A (en) * 1989-12-12 1993-05-04 Burroughs Wellcome Co. Method for administering pharmaceuticals, including liquid surfactant, to the lungs
FR2658418B1 (fr) * 1990-02-20 1994-09-02 Synthelabo Compositions pharmaceutiques a base de phospholipides.
CA2083171C (en) * 1990-05-18 2002-09-10 Kurashima Kazuyoshi Antasthmatic
US5614216A (en) * 1990-10-17 1997-03-25 The Liposome Company, Inc. Synthetic lung surfactant
JP3961029B2 (ja) * 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
CO5021218A1 (es) * 1994-12-29 2001-03-27 Ct Nac De Sanidad Agropecuaria Surfactante pulmonar natural porcino
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
CA2244767C (en) * 1996-01-24 2005-11-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Process for the production of powdered pulmonary surfactant preparations
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
AU2322097A (en) * 1996-03-27 1997-10-17 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
US5667948A (en) * 1996-04-16 1997-09-16 Eastman Kodak Company Processing silver halide films with an aqueous phospholipid rinse solution
EP1054679B1 (en) 1997-12-24 2003-02-12 Britannia Pharmaceuticals Limited Use of surface active agent for the manufacture of a medicament for treatment of disorders of the middle ear
EP1216052A1 (en) 1999-09-16 2002-06-26 Byk Gulden Lomberg Chemische Fabrik GmbH Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
GB0026239D0 (en) * 2000-10-26 2000-12-13 Britannia Pharmaceuticals Ltd Surface active lipids in treatment of wet lung
CA2453538A1 (en) * 2001-07-12 2003-01-23 Kyowa Medex Co., Ltd. Method for determination of denatured lipoprotein, reagent for determination of denatured lipoprotein, method for detection of cardiovascular disease, and reagent for detection ofcardiovascular disease
JP4559731B2 (ja) 2001-10-11 2010-10-13 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 肺サーファクタントの新規使用
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
EP1781323B1 (en) 2004-08-06 2010-02-17 Nycomed GmbH Composition comprising a pulmonary surfactant and a tnf-derived peptide
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
EP2370068A4 (en) 2008-12-10 2015-09-23 Paka Pulmonary Pharmaceuticals Inc METHOD AND COMPOSITIONS FOR DELIVERING MEDICAMENTS TO THE LUNG
EA201300255A1 (ru) 2010-08-23 2013-06-28 Такеда Гмбх Увлажненные частицы, содержащие терапевтически активное вещество
EP2837377A1 (en) * 2012-03-28 2015-02-18 Discovery Laboratories, Inc. Lyophilization of synthetic liposomal pulmonary surfactant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE388023C (de) * 1922-02-14 1924-01-07 Chem Fab Verfahren zur Herstellung von waesserigen Lezithinemulsionen
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees
DE2900300A1 (de) * 1979-01-05 1980-07-17 Lebrecht Von Dr Klitzing Verfahren einer prophylaxe zur vermeidung des atemnotsyndroms bei fruehgeborenen und bei der schocklunge
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤

Also Published As

Publication number Publication date
US4603124A (en) 1986-07-29
EP0119056A2 (en) 1984-09-19
CA1208129A (en) 1986-07-22
AU2512584A (en) 1984-09-13
JPH0378371B2 (OSRAM) 1991-12-13
AU562676B2 (en) 1987-06-18
GR81930B (OSRAM) 1984-12-12
ATE55908T1 (de) 1990-09-15
IE57006B1 (en) 1992-03-11
DE3483055D1 (de) 1990-10-04
JPS59164724A (ja) 1984-09-17
EP0119056A3 (en) 1986-06-25
EP0119056B1 (en) 1990-08-29
IE840553L (en) 1984-09-10

Similar Documents

Publication Publication Date Title
MX9203493A (es) Surfactantes y remedios para sindrome de tension respiratoria que contienen los mismos.
JPS5799524A (en) Mammal lung surface active drug composition
Heppleston et al. Changes in the composition of lung lipids and the “turnover” of dipalmitoyl lecithin in experimental alveolar lipo-proteinosis induced by inhaled quartz
ATE38329T1 (de) Lungensurfactant.
NO900604D0 (no) Fremgangsmaate ved fremstilling av et terapeutisk system for transdermal eller transmucosal administrering av virkestoffer og dets anvendelse.
DE10299015I1 (de) Arzneimittel enthaltend Dipyridamol oder Mopidamol und O-Acetylsalicylsaeure bzw deren physiologisch vertraegliche Salze Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekaempfung der Thrombusbildung
AU4299689A (en) Biologicaly active lipoprotein and its use
ES2037725T3 (es) Procedimiento para la preparacion de acidos dicarboxilicos alfa-halogenados.
AR227031A1 (es) Esteres alquilicos del acido n'-(fenilsulfonil)-n-((1,-3,5-triazin o pirimidin)-2-il)carbamimidico y una composicion para el control de la vegetacion no deseada que los contiene
BR8402324A (pt) Processo para a preparacao de esteres de acido pirimidin-5-il-tionofosforico,composicao praguicida,e processos para combater pragas e para a preparacao de composicoes
ES502080A0 (es) Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina
Robertson Lung surfactant for replacement therapy
JPS56127308A (en) Blood-coagulation factor 8 pharmaceutical
MX172808B (es) Trigliceridos que contienen acidos grasos saturados que tienen de 20 a 24 atomos de carbono utiles para disminuir los niveles de colesterol en la sangre
ES482684A1 (es) Procedimiento de preparacion de nuevos derivados de la pipe-ridilbencimidazolinona y de sus sales de adicion con acidos apropiados.
ES355995A1 (es) Un procedimiento para la preparacion de una composicion li-quida destinada a ser utilizada para la limpieza y la desin-fectacion de aparatos a base de porcelana.
DE3362256D1 (en) 4-(trans-4'-alkyloxymethylcyclohexyl) benzoic acid esters
ES8605533A1 (es) Procedimiento para la preparacion de esteres fosfato ciclicode 9-1,3-dihidroxi-2-propoximetil-guanina
DK150481C (da) Analogifremgangsmaade til fremstilling af 3',4'-dihydro-spiro-(imidazolidin-4,1'-(2'h)-naphthalen)-5-on eller farmaceutisk acceptable syreadditionssalte deraf
PT96287A (pt) Processo para a preparacao de derivados do acido 2-formilbenzilfosfonico e de composicoes farmaceuticas que os contem
Sanborn Clinico-pathologic aspects of traumatic wet lung
BR8100315A (pt) Processo para a preparacao de esteres de indan-4-ilo de acidos n-alquil-carbamicos, composicoes fungicidas, processo para o combate de fungos e processo para preparar composicoes fungicidas
ES2092969A1 (es) Surfactante pulmonar natural de origen porcino.
ES534907A0 (es) Procedimiento para disminuir el contenido de fluor de un acido fosforico de procedimiento en humedo
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters